Visit us in Boston at ASGCT 2026
Meet Us at Booth #956
Connect with our experts to see how Tapestri’s multiomic single-cell platform characterizes outcomes for in vivo and engineered therapies. Overcoming legacy limitations, we deliver actionable data on genome integrity, genotoxicity, biodistribution, and true VCN in days, helping you confidently meet rising regulatory standards.
→ Schedule time to meet with us.
Quantifying CRISPR multiplexed edits and targeted gene expression at single-cell resolution to define Critical Quality Attributes (CQA) in CGT development
Discover how Mission Bio is advancing analytical strategies for cell and gene therapy developers by enabling precise measurement of editing efficiency, co-occurrence, and downstream gene expression in the same cells.
Must See Data
“Single-cell multiomic evaluation of allelic zygosity, edit co-occurrence, and gene expression for analytical characterization of CRISPR edited multiplex-engineered cell therapies”
- Abstract ID: 1246
- Presentation Day: May 12, 2026
- Poster Reception: 5:00 PM – 6:30 PM
Stop by to see how integrated DNA + RNA analysis at single-cell resolution enables deeper insight into gene editing outcomes and cellular function relevant for cell therapy manufacturing.
Tapestri Treats (Wednesday Only!)
Swing by the booth on Wednesday at 2:00 PM EST for Tapestri TreatsWe’re serving up a limited batch of surprise refreshments… with a cool twist.
(Hint: think liquid nitrogen)